19 related articles for article (PubMed ID: 3033617)
1. Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response.
Balkan B; Pogun S
Curr Neuropharmacol; 2018; 16(4):371-387. PubMed ID: 28730966
[TBL] [Abstract][Full Text] [Related]
2. The delta opioid receptor antagonist, SoRI-9409, decreases yohimbine stress-induced reinstatement of ethanol-seeking.
Nielsen CK; Simms JA; Bito-Onon JJ; Li R; Ananthan S; Bartlett SE
Addict Biol; 2012 Mar; 17(2):224-34. PubMed ID: 21309957
[TBL] [Abstract][Full Text] [Related]
3. Involvement of mu-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats.
degli Uberti EC; Petraglia F; Bondanelli M; Guo AL; Valentini A; Salvadori S; Criscuolo M; Nappi RE; Genazzani AR
J Endocrinol Invest; 1995 Jan; 18(1):1-7. PubMed ID: 7759779
[TBL] [Abstract][Full Text] [Related]
4. Effects of (D-ala2, met5)-enkephalinamide and naloxone on ACTH and corticosterone secretion.
Hashimoto K; Suemaru S; Hattori T; Takao T; Inoue H; Sugawara M; Kageyama J; Ota Z
Endocrinol Jpn; 1986 Dec; 33(6):813-20. PubMed ID: 3034557
[TBL] [Abstract][Full Text] [Related]
5. Effect of morphine on hypothalamic corticotropin-releasing factor (CRF) and pituitary-adrenocortical activity.
Suemaru S; Hashimoto K; Ota Z
Endocrinol Jpn; 1986 Aug; 33(4):441-8. PubMed ID: 3024953
[TBL] [Abstract][Full Text] [Related]
6. D-Ala2-Met-enkephalinamide, a potent opioid peptide, alters pituitary-adrenocortical secretion in rats.
De Souza EB; Van Loon GR
Endocrinology; 1982 Nov; 111(5):1483-90. PubMed ID: 6290184
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamo-pituitary-interrenal responses to opioid substances in the trout. II. Effects of morphine and D-Ala2, Met5-enkephalinamide on plasma cortisol titres in vivo.
Mukherjee S; Baker BI; Bird DJ; Buckingham JC
Gen Comp Endocrinol; 1987 Oct; 68(1):40-8. PubMed ID: 2822527
[TBL] [Abstract][Full Text] [Related]
8. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
Neuropeptides; 2014 Feb; 48(1):15-20. PubMed ID: 24331779
[TBL] [Abstract][Full Text] [Related]
9. Dual effects of (D-Ala2,Met5)-enkephalinamide on CRF and ACTH secretion.
Hashimoto K; Suemaru S; Ono N; Hattori T; Inoue H; Takao T; Sugawara M; Kageyama J; Ota Z
Peptides; 1987; 8(1):113-8. PubMed ID: 3033617
[TBL] [Abstract][Full Text] [Related]
10. Control of ACTH secretion by corticotropin-releasing factor(s).
Brodish A
Vitam Horm; 1979; 37():111-52. PubMed ID: 232792
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
